Document:USA Informed Consent - FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023: Difference between revisions
From GxPlex
Gxplex admin (talk | contribs) m 1 revision imported |
Remove static References table, superseded by live #ask in Template:DocumentData (GxPlexBot) |
||
| (7 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{DocumentData | |||
|reference=USA Informed Consent - | |reference=USA Informed Consent - | ||
FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 | FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 | ||
| Line 35: | Line 17: | ||
|contributors= | |contributors= | ||
}} | }} | ||
Latest revision as of 14:15, 16 July 2026
| Document information | |
|---|---|
| Reference | USA Informed Consent -
FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 |
| Validity area | USA |
| Scope(s) | G |
| Document name | Informed Consent -
FDA Guidance for IRBs, Clinical Investigators, and Sponsors |
| Version / Revision | Aug-2023 |
| Status | Current |
| Document type | Official recommendation |
| Language(s) | EN |
| Description | Informed Consent
Guidance for IRBs, Clinical Investigators, and Sponsors |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
References
| Scope | Document part | Language | Preview | |
|---|---|---|---|---|
| USA Informed Consent - FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 II. Advertising-001 | G | II. Advertising | EN | II. SUMMARY OF THE CONSENT PROCESS
[…] FDA considers advertising used to recruit subjects into the clinical trial to be the start of the ongoing conse… |
| USA Informed Consent - FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 II. Advertising-002 | G | II. Advertising | EN | II. SUMMARY OF THE CONSENT PROCESS
[…] FDA considers advertising used to recruit subjects into the clinical trial to be the start of the ongoing conse… |
| USA Informed Consent - FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 II. Introduction | G | II. Introduction | EN | II. SUMMARY OF THE CONSENT PROCESS To many, the term informed consent is mistakenly viewed as synonymous with obtaining a subject’s signature on the c… |
| USA Informed Consent - FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 III. | G | III. | EN | III. FDA INFORMED CONSENT REQUIREMENTS AND DISCUSSION
[…] E. Documentation of Informed Consent [...] b. Short Form An IRB may approve a short form to … |
| USA Informed Consent - FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 IV. | G | IV. | EN | IV. RESPONSIBILITIES FOR INFORMED CONSENT
[…] B. The Clinical Investigator The clinical investigator is responsible for protecting the rights, safety,… |
| USA Informed Consent - FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 V. | G | V. | EN | V. FREQUENTLY ASKED QUESTIONS
[…] 1. What are some considerations for enrolling a child into a clinical investigation? [...] 2. Are there any addition… |
